Combination immunotherapy for non-small cell lung cancer
- 1 January 1990
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 99 (1) , 8-13
- https://doi.org/10.1016/s0022-5223(19)35625-9
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Induction of lymphokine-activated killer cytotoxicity with interleukin-2 and tumor necrosis factor-? against primary lung cancer targetsCancer Immunology, Immunotherapy, 1989
- Phase I trial of intramuscularly administered tumor necrosis factor in patients with advanced cancer.Journal of Clinical Oncology, 1989
- Repetitive Weekly Cycles of Recombinant Human Interleukin-2: Responses of Renal Carcinoma With Acceptable Toxicity1JNCI Journal of the National Cancer Institute, 1988
- Combination tumor-immunotherapy with recombinant tumor necrosis factor and recombinant interleukin 2 in miceInternational Journal of Cancer, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancerCancer Immunology, Immunotherapy, 1987
- Therapy of Cancer Using the Adoptive Transfer of Activated Killer Cells and Interleukin-2Acta Haematologica, 1987
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985